BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8058441)

  • 21. Cancer incidence among children in France, 1990-1999.
    Desandes E; Clavel J; Berger C; Bernard JL; Blouin P; de Lumley L; Demeocq F; Freycon F; Gembara P; Goubin A; Le Gall E; Pillon P; Sommelet D; Tron I; Lacour B
    Pediatr Blood Cancer; 2004 Dec; 43(7):749-57. PubMed ID: 15390289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
    Kristinsson JK
    Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [DISTRIBUTION OF ABO, RH, AND KELL ANTIGENS IN THE AUVERGNE POPULATION (PUY-DE-DOME, CANTAL, HAUTE-LOIRE)].
    DERYCKE C; HABOUZIT A; LAGET R; MOULLEC J; NGUYENVAN CONG
    Transfusion (Paris); 1965; 8():37-40. PubMed ID: 14298735
    [No Abstract]   [Full Text] [Related]  

  • 24. Folic acid food fortification is associated with a decline in neuroblastoma.
    French AE; Grant R; Weitzman S; Ray JG; Vermeulen MJ; Sung L; Greenberg M; Koren G
    Clin Pharmacol Ther; 2003 Sep; 74(3):288-94. PubMed ID: 12966372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A lack of neuroblastoma in Down syndrome: a study from 11 European countries.
    Satgé D; Sasco AJ; Carlsen NL; Stiller CA; Rubie H; Hero B; de Bernardi B; de Kraker J; Coze C; Kogner P; Langmark F; Hakvoort-Cammel FG; Beck D; von der Weid N; Parkes S; Hartmann O; Lippens RJ; Kamps WA; Sommelet D
    Cancer Res; 1998 Feb; 58(3):448-52. PubMed ID: 9458088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuroblastoma: is systemic screening possible?].
    Farriaux JP
    Arch Pediatr; 1994 Dec; 1(12):1075-8. PubMed ID: 7849891
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lorraine childhood cancer registry: incidence, survival 1983-1999].
    Lacour B; Desandes E; Mallol N; Sommelet D
    Arch Pediatr; 2005 Nov; 12(11):1577-86. PubMed ID: 16099145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Report of the 1998 Consensus Conference on Neuroblastoma Screening.
    Med Pediatr Oncol; 1999 Oct; 33(4):357-9. PubMed ID: 10491542
    [No Abstract]   [Full Text] [Related]  

  • 29. Contribution of HPLC mass screening for neuroblastoma to a decrease in mortality.
    Nishi M; Takeda T; Hatae Y; Hanai J; Fujita K; Ichimiya H; Tanaka T
    J Exp Clin Cancer Res; 2002 Mar; 21(1):73-8. PubMed ID: 12071533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis of insulin-dependent diabetes in children: data from the incidence registry].
    Doutreix J; Lévy-Marchal C
    Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S90-6. PubMed ID: 8935870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France].
    Minodier P; Robert S; Noël G; Blanc P; Retornaz K; Garnier JM
    Arch Pediatr; 2005 Jul; 12(7):1102-8. PubMed ID: 15964525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folic acid and neuroblastoma: too soon to tell.
    Barone BB; Bunin GR
    Clin Pharmacol Ther; 2004 May; 75(5):489; author reply 490. PubMed ID: 15116062
    [No Abstract]   [Full Text] [Related]  

  • 33. Lead-time and overdiagnosis estimation in neuroblastoma screening.
    Spix C; Michaelis J; Berthold F; Erttmann R; Sander J; Schilling FH
    Stat Med; 2003 Sep; 22(18):2877-92. PubMed ID: 12953286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival of children with neuroblastoma prior to the neuroblastoma screening project in Germany.
    Burkhardt-Hammer T; Spix C; Brenner H; Kaatsch P; Berthold F; Hero B; Michaelis J
    Med Pediatr Oncol; 2002 Sep; 39(3):156-62. PubMed ID: 12210443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Birth characteristics and risk of neuroblastoma in young children.
    Urayama KY; Von Behren J; Reynolds P
    Am J Epidemiol; 2007 Mar; 165(5):486-95. PubMed ID: 17164463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of herpes simplex virus keratitis in France.
    Labetoulle M; Auquier P; Conrad H; Crochard A; Daniloski M; Bouée S; El Hasnaoui A; Colin J
    Ophthalmology; 2005 May; 112(5):888-95. PubMed ID: 15878072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compliance in a screening program for neuroblastoma.
    Campion P; Woods WG; Lemieux B
    Prev Med; 1998; 27(4):590-6. PubMed ID: 9672953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, Brazil.
    Pianovski MA; Maluf EM; de Carvalho DS; Ribeiro RC; Rodriguez-Galindo C; Boffetta P; Zancanella P; Figueiredo BC
    Pediatr Blood Cancer; 2006 Jul; 47(1):56-60. PubMed ID: 16200634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of an apparent cluster of Crohn's disease cases in Indre-et-Loire, France (1990-1999)].
    Valenciano M; Gagnière B; Maurage C; de Valk H; Desenclos JC
    Rev Epidemiol Sante Publique; 2002 Dec; 50(6):509-17. PubMed ID: 12515921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the Cessation of Mass Screening for Neuroblastoma at 6 Months of Age: A Population-Based Study in Osaka, Japan.
    Ioka A; Inoue M; Yoneda A; Nakamura T; Hara J; Hashii Y; Sakata N; Yamato K; Tsukuma H; Kawa K
    J Epidemiol; 2016; 26(4):179-84. PubMed ID: 26548355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.